Where does Applaud Medical, Inc. rank among US patent assignees?

According to USPTO PatentsView (2015–2025 granted utility patents), Applaud Medical, Inc. ranks #38,821 of 49,997 assignees by granted-patent volume, the same sort as the companies listing and top-holders ranking. See /methodology/#corpus-placement.

How many patents does Applaud Medical, Inc. hold?

Applaud Medical, Inc. holds 6 US utility patents granted between 2021 and 2024, spanning 8 technology areas.

What is Applaud Medical, Inc.'s Innovation Score?

Applaud Medical, Inc. has an Innovation Score of 50.9 out of 100 (top 12% of the corpus). This composite metric weighs portfolio volume (40%), grant velocity (20%), technology breadth (25%), and claim depth (15%).

What technology areas does Applaud Medical, Inc. focus on?

Applaud Medical, Inc.'s top technology area is A61P (Specific Therapeutic Activity OF Chemical Compounds OR Medicinal Preparations) with 4 patents, ranking #4,040 of 6,058 assignees active in that subclass. Grants appear in 8 CPC subclasses total.

Is Applaud Medical, Inc.'s patent grant rate increasing or decreasing?

Insufficient historical data is available to calculate a velocity trend for Applaud Medical, Inc..

What does claim depth mean for Applaud Medical, Inc.'s patents?

Applaud Medical, Inc.'s patents average 23.7 claims each. This is an aggregate descriptive count from the grant record; it does not establish claim scope, legal strength, enforceability, or design-around risk.

How is the Applaud Medical, Inc. patent data sourced?

All patent data comes from USPTO PatentsView, a public research dataset maintained by the United States Patent and Trademark Office covering US granted utility patents from 2015 to 2025.

USPTO 2015–2025 USPTO PatentsView US Corporation

Applaud Medical, Inc.

USPTO PatentsView assignee record - 6 granted patents across 8 technology areas, recorded in grant years 2021–2024. Grant-trend analysis is cross-referenced to USPTO Patent Public Search; it does not measure application filings, current R&D, or legal strength. Primary class: A61P (Specific Therapeutic Activity OF Chemical Compounds OR Medicinal Preparations).

Compiled by PlainPatent · May 15, 2026

RSS updates for this company

Explore the portfolio See the ranking

The verdict

According to USPTO PatentsView, Applaud ranks #38,821 of 49,997 tracked US assignees by granted-patent volume, with 6 patents across 8 technology areas.

#38,821
of 49,997 US assignees by volume: Top 12%
by Innovation Score (50.9/100): 23.7
avg claims per patent

USPTO PatentsView assignee plate

Corpus R38821 · US Corporation #38,821 · 6 grants

GRANTS-MICRO · LOWER-Q · PHOTO-FINISH · CPC-NARROW · INNOV-PAR · CLAIMS-DENSE · TYPE-USCORP · SPAN-YRS · BOOK-RICH

GRANTS-MICRO 6 grants
LOWER-Q #38,821/49,997
PHOTO-FINISH Apollo Energy Services
CPC-NARROW A61P · 8 areas
INNOV-PAR 50.9/100
CLAIMS-DENSE 23.7 claims/avg
TYPE-USCORP US Corporation
SPAN-YRS 2021–2024 · 4y
BOOK-RICH 9/10 fields

Nearest grant-volume peer: Apollo Energy Services Corp. (±0 grants)

Instrument codes from this assignee’s USPTO PatentsView grant sheet: volume band, corpus rank, photo-finish peer, lead CPC, Innovation Score, claim depth, assignee type, velocity, and book completeness. Not a USPTO rating of patent strength.

How Applaud’s 50.9 Innovation Score adds up

The same four weighted components behind every Innovation Score on PlainPatent: portfolio volume, grant velocity, technology breadth, and claim depth.

Volume 6.7 pts (13%) Velocity 20.0 pts (39%) Breadth 10.0 pts (20%) Claim depth 14.2 pts (28%)

Qualcomm Incorporated · highest

85
Applaud Medical · this assignee

51
3D Lighting… · lowest

7

What this shows Applaud's Innovation Score is 50.9/100 (top 12% of the PatentsView-derived corpus). The chart places that score against the nearest Innovation Score peers plus corpus poles, not a reprint of the volume ranking.

Does more volume mean deeper claims for Applaud?

Each dot is one of Applaud’s 8 nearest volume peers (same corpus rank neighbourhood as the chart above), placed by total granted patents (horizontal) against average claims per patent (vertical). Applaud’s own 23.7 claims/patent is ABOVE the 17.2 median for these volume peers. More thorough claims than most filers at this scale, not just more of them.

Applaud vs its 8 nearest volume peers: granted patents vs average claims per patent. Source: USPTO PatentsView.

Where Applaud's grants concentrate

Applaud Medical, Inc. is a focused PatentsView assignee: 8 CPC subclasses with 66.7% of grants classified under A61P (Specific Therapeutic Activity OF Chemical Compounds OR Medicinal Preparations). Peak complete grant year is 2022 (2 grants) versus a trough of 1 in 2021. By volume, Applaud sits between Apollo Energy Services Corp. and Aprinoia Therapeutics Limited.

Applaud's three-year grant acceleration

Applaud Medical, Inc. shows 5 grants in 2022–2024 against only 1 in 2019–2021. That prior window is too thin for a growth multiple (rename and spin-out assignees look artificially high when the baseline is near zero), so PlainPatent withholds a ranked acceleration claim here.

Apollo Energy Ser…

6
App-pop-up

6
Appdome

6
Appfolio

6
Applied Food Biot…

6
Applied Lacquer I…

6
Applikate

6
Aprinoia Therapeu…

6
Applaud Medical ◀

6

What this shows Applaud holds 6 patents at rank #38,661, shown against the 8 assignees closest to it in grant volume rather than the industry's largest filers.

Companies ranked near Applaud

By rank, the assignees closest to #38,661 in granted patent volume.

Leaders in A61P (Specific Therapeutic Activity OF Chemical Compounds OR Me…)

Other assignees with the most granted patents in Applaud's primary technology class.

Applaud's Innovation Score vs. every tracked assignee

Composite of portfolio volume, grant velocity, technology breadth, and claim depth (0–100)

51 Top 12% higher than 88% of 49,997 US assignees

Each bar is a band; taller bars hold more US assignees. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count, share, and where it sits relative to this entry.

Source USPTO PatentsView, PlainPatent Innovation Score · 2015–2025

USPTO utility patent grants by year · 2021–2024

Grants by year

Teal-shaded recent years (2020–present) versus the 2021–2019 baseline. Full figures in the table below.

View data table

Applaud Medical, Inc. patent grants by year, 2015–2025
Year	Patents Granted	Share of Period
2021	1	16.7%
2022	2	33.3%
2023	1	16.7%
2024	2	33.3%

Which technologies does Applaud Medical, Inc. patent most?

A61P - Specific Therapeutic Activity OF Chemical Compounds OR Medicinal Preparations 4

A61K - Preparations FOR Medical, Dental OR Toiletry Purposes 4

C07F - Acyclic, Carbocyclic OR Heterocyclic Compounds Containing Elements Other Than Carbon, Hydrogen, Halogen, Oxygen, Nitrogen, Sulfur, Selenium OR Tellurium 4

A61B - DIAGNOSIS; SURGERY; Identification 2

G01S - Radio DIRECTION-FINDING; Radio NAVIGATION; Determining Distance OR Velocity BY USE OF Radio WAVES; Locating OR Presence-detecting BY USE OF THE Reflection OR Reradiation OF Radio WAVES; Analogous Arrangements Using Other Waves 2

A61N - ELECTROTHERAPY; MAGNETOTHERAPY; Radiation THERAPY; Ultrasound Therapy 2

Y02A - Technologies FOR Adaptation TO Climate Change 2

G16H - Healthcare Informatics, i.e. Information AND Communication Technology [ICT] Specially Adapted FOR THE Handling OR Processing OF Medical OR Healthcare Data 2

Top 8 of 8 technology areas

More on this record

Data Source

USPTO PatentsView, US granted patents 2015–2025

View all rankings → How is Innovation Score calculated?

What to do with this data

Applaud Medical, Inc.'s patent record in context - here's where to go next.

Applaud Medical, Inc.'s lead technology class is A61P (Specific Therapeutic Activity OF Chemical Compounds OR Medicinal Preparations), 66.7% of its portfolio - see every assignee active in that class. Explore A61P
Ranked #38,821 of 49,997 tracked assignees by patent volume - see the full leaderboard. See the ranking
Compare Applaud Medical, Inc. against Apollo Energy Services Corp., an assignee filing at a similar volume. Compare portfolios
Innovation Score of 50.9/100 blends volume, velocity, technology breadth, and claim depth. How it's calculated

Figures reflect USPTO PatentsView grant data through May 2026; pending applications not yet granted are not counted.

Data sourced from USPTO PatentsView - official U.S. government patent data. See our methodology for computation details. Retrieved and formatted by PlainPatent

Disclaimer: This information is provided for informational purposes only and does not constitute professional advice. Data is sourced from the USPTO PatentsView database. Consult a qualified professional before making decisions based on this data.

Read our methodology - how this data is sourced, computed, and verified.

Data sources used on this page

USPTO PatentsView - the disambiguated bulk patent-grant, assignee, and CPC data this page's figures are derived from. patentsview.org
Cooperative Patent Classification (CPC) - the joint USPTO/EPO classification scheme used to group patents by technology area. cooperativepatentclassification.org
USPTO Patent Public Search - the official interface to verify the status of any individual patent. ppubs.uspto.gov

Compiled by PlainPatent , US Patent Intelligence Editorial Process · May 15, 2026

Every figure on PlainPatent is rendered directly from USPTO source data, no number is typed in by an editor. This page draws directly on USPTO source data, no figure is typed in by an editor. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error. Data current as of May 2026.